| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Phenylephrine hydrochloride |
Is a |
False |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Phenylephrine measurement |
Component |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Phenylephrine adverse reaction |
Causative agent (attribute) |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Allergy to phenylephrine |
Causative agent (attribute) |
False |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Phenylephrine eye drops (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Chlorpheniramine maleate+phenylephrine hydrochloride+phenyltoloxamine citrate 4mg/20mg/50mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Chlorpheniramine maleate+phenylephrine hydrochloride+phenyltoloxamine citrate 2.5mg/5mL 5mg/5mL 7.5mg/5mL liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Phenylephrine tannate 1 mg/mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Acetaminophen+chlorpheniramine maleate+phenylephrine hydrochloride 500mg/8mg/40mg caplets |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Chlorpheniramine maleate + hydrocodone bitartrate + phenylephrine hydrochloride 2mg/2.5mg/5mg liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Phenylephrine hydrochloride + promethazine hydrochloride 5mg/6.25mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Phenylephrine hydrochloride + sulfacetamide sodium 1.25mg/150mg solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Decongestant phenylephrine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Phenylephrine-containing product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Phenylephrine-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing phenylephrine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Phenylephrine 0.125% solution nasal drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Phenylephrine 0.25% solution nasal |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Phenylephrine 0.25% solution oral drop |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Phenylephrine 0.5% solution nasal |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Phenylephrine 1% solution nasal |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing phenylephrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Chlorphenamine maleate 4 mg and mepyramine maleate 25 mg and phenylephrine hydrochloride 10 mg and phenylpropanolamine 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Neo synephrine hydrochloride 1% (10mg/mL) injection solution 1mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Phenylephrine hydrochloride 1% (10mg/mL) injection solution 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Phenylephrine hydrochloride 1% (10mg/mL) injection solution 1mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Phenylephrine hydrochloride 1% (10mg/mL) injection solution 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hypromellose+phenylephrine 0.5/0.12% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hypromellose- and phenylephrine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing benzocaine and phenazone and phenylephrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Chlorphenamine- and mepyramine- and phenylephrine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Hydrocodone- and phenylephrine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing codeine and phenylephrine and promethazine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing dextromethorphan and phenylephrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing pheniramine and phenylephrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Chlorphenamine- and phenylephrine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing chlorphenamine and codeine and phenylephrine and potassium iodide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Chlorphenamine- and ephedrine- and pentoxyverine- and phenylephrine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing guaifenesin and phenylephrine and phenylpropanolamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing guaifenesin and phenylephrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Brompheniramine maleate + phenylephrine+ phenylpropanolamine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| chlorhydrate de phényléphrine 10 mg/1 mL, pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely lidocaine hydrochloride 50 milligram/1 milliliter and phenylephrine hydrochloride 5 milligram/1 milliliter conventional release solution for cutaneous spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing lidocaine and phenylephrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing phenylephrine and promethazine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing cyclopentolate and phenylephrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Phenylephrine 5mg/promethazine 6.25mg/codeine 10mg in 5mL oral syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing paracetamol and phenylephrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Phenylephrine-containing product in nasal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Phenylephrine-containing product in otic dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Phenylephrine-containing product in rectal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing phenylephrine in topical dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Allergy to phenylephrine |
Causative agent (attribute) |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Ketorolac- and phenylephrine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Ketorolac- and phenylephrine-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Phenylephrine bitartrate |
Is a |
False |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Phenylephrine hydrochloride |
Is modification of (attribute) |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Phenylephrine bitartrate |
Is modification of (attribute) |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Chlorpheniramine maleate+phenylephrine hydrochloride+phenyltoloxamine citrate 4mg/20mg/50mg prolonged-release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing chlorphenamine and mepyramine and phenylephrine and phenylpropanolamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing chlorphenamine and mepyramine and phenylephrine and phenylpropanolamine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing phenylephrine in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing lidocaine and phenylephrine in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Chlorphenamine and phenylephrine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Chlorphenamine and ephedrine and pentoxyverine and phenylephrine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only chlorphenamine and codeine and phenylephrine and potassium iodide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Benzocaine and phenazone and phenylephrine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only chlorphenamine and mepyramine and phenylephrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only chlorphenamine and mepyramine and phenylephrine and phenylpropanolamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only dextromethorphan and phenylephrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only cyclopentolate and phenylephrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Codeine and phenylephrine and promethazine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Ketorolac and phenylephrine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing only hydrocodone and phenylephrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing only phenylephrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Phenylephrine and promethazine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Lidocaine and phenylephrine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only paracetamol and phenylephrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Hypromellose and phenylephrine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only guaifenesin and phenylephrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Guaifenesin and phenylephrine and phenylpropanolamine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only pheniramine and phenylephrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only lidocaine and phenylephrine in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Chlorphenamine and mepyramine and phenylephrine and phenylpropanolamine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Phenylephrine only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only phenylephrine in nasal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Phenylephrine only product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only phenylephrine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only phenylephrine in otic dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only phenylephrine in rectal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only phenylephrine in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Ketorolac and phenylephrine only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Phenylephrine tannate |
Is modification of (attribute) |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely phenylephrine 2.5 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has basis of strength substance (attribute) |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely phenylephrine 2.5 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has precise active ingredient |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Chlorphenamine and phenylephrine and phenyltoloxamine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing codeine and phenylephrine and promethazine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Chlorphenamine and phenylephrine and phenyltoloxamine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing chlorphenamine and phenylephrine and phenyltoloxamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing chlorphenamine and phenylephrine and phenyltoloxamine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing cyclopentolate and phenylephrine in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenylephrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]